Search Results for "Mrm Proteomics Inc"

04:42 EDT 23rd October 2014 | BioPortfolio

Original Source: MRM Proteomics Inc.

MRM Proteomics is a leading provider of advanced protein quantification, biomarker and proteomic services to the pharmaceutical, biotechnology and diagnostics industries. We are specialists in quantitative targeted proteomics through the use and development of Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). Our MRM-MS platform technology has a wide number of applications in drug discovery and clinical development particularly with regards to biomarker discovery/validation, drug t...

Matching Channels

Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...


With the United Kingdom, Scotland represents a long-standing center of biotechnological excellence, ranked in the top 5 in the world. Over the years, the following important developments have occurr...

Matching News

Race for Proteomics Knowledge Spurs Investment and Partnerships

Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information.  The healthcare market research publisher said that over 100 deals had occurred in p...

The AAPS Journal: Quantitative Targeted Proteomics for Membrane Transporter Proteins: Method and Application

Type: Original PaperAlthough global proteomics has shown promise for discovery of many new proteins, biomarkers, protein modifications, and polymorphisms, targeted proteomics is emerging in the proteo...

Exclusive partnership brings together next-generation proteomics and next-generation sequencing

AB SCIEX and Illumina (NASDAQ: ILMN) announced today the OneOmics™ project, an exclusive partnership to bring together SWATH™-based next-generation proteomics (NGP) and next-generation sequencing ...

Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics

The results of genome-wide association studies are combined with quantitative interaction proteomics to narrow down the list of putative causal disease genes and filter modest association signals.

Applying Proteomics to Parkinson’s

Scientists studying two genes that are mutated in an early-onset form of Parkinson’s disease have deciphered how normal versions of these genes collaborate to help rid cells of damaged mitochondria....

Illumina Opens BaseSpace to Proteomics Data

Bio-IT World | The OneOmics Project, a partnership between Illumina and mass spectrometry provider AB SCIEX, has produced a network of apps in the BaseSpace cloud informatics environment to store and ...

Elsevier journal Translational Proteomics endorsed by the Human Proteome Organization

(Elsevier) Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Human Proteome Organization (HUPO) are delighted to announce HUPO's affili...

TripleTOF System for Quantitative Proteomics

AB SCIEX introduced the TripleTOF 6600 system with SWATH Acquisition 2.0—the company’s solution for quantitative proteomics. This high-resolution, accurate-mass system, combined with the new SWATH...

Matching PubMed Articles

The 8th International Conference of the Canadian Proteomics Initiative.

The 8th International Conference of the Canadian Proteomics Initiative (CPI) was held at the Hilton Vancouver Metrotown Hotel in Burnaby, British Columbia from 3-5 May, 2008. With nearly 200 delegates...

Cover picture: proteomics 9'14.

The large figure on the cover page has kindly been provided by Dr. Alexandre Zougman, St. James's University Hospital, Leeds, UK (please also see the contribution in this issue: Zougman, A., Selby, P....

"Post-publication notes to J. Proteomics 2012; 75:2433 and J. Proteomics 2012; 75:2443"

Editorial board: Proteomics 3-4'14.

Cover picture: proteomics 1-2'14.

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement